ABSTRACT
The Warburg micro syndrome (WARBM) is a genetically heterogeneous syndrome linked to at least 4 loci. At the clinical level, WARBM is characterized by microcephaly, microphthalmia, microcornea, congenital cataracts, corpus callosum hypoplasia, severe mental retardation, and hypogonadism. In some families additional clinical features have been reported. The presence of uncommon clinical features (peripheral neuropathy, cardiomyopathy) may result in misdirected molecular diagnostics. Using the next generation sequencing approach (NGS), we were able to diagnose WARBM1 syndrome by detection of a new mutation within the RAB3GAP1 gene. We have detected some DNA variants which may be responsible for cardiomyopathy. We did not find any obvious pathogenic mutation within a set of genes known to be responsible for hereditary motor and sensory neuropathy (HMSN). We conclude that: (i) in clinically delineated syndromes, a classical single-gene oriented approach may be not conclusive especially in the presence of rare clinical features, (ii) peripheral neuropathy and cardiomyopathy are rare additional symptoms coexisting with WARBM1, (iii) a pleiotropic effect of a single point mutation is sufficient to be causative for WARBM1 and (iv) more WARBM-affected patients should be reported to delineate a complete phenotype.
Subject(s)
Abnormalities, Multiple/genetics , Cataract/congenital , Cornea/abnormalities , Hypogonadism/genetics , Intellectual Disability/genetics , Microcephaly/genetics , Mutation/genetics , Optic Atrophy/genetics , Peripheral Nervous System Diseases/genetics , Abnormalities, Multiple/diagnosis , Agenesis of Corpus Callosum/diagnosis , Agenesis of Corpus Callosum/genetics , Cardiomyopathies/diagnosis , Cardiomyopathies/genetics , Cataract/complications , Cataract/diagnosis , Cataract/genetics , Child, Preschool , Female , High-Throughput Nucleotide Sequencing/methods , Humans , Hypogonadism/complications , Hypogonadism/diagnosis , Infant , Intellectual Disability/complications , Intellectual Disability/diagnosis , Microcephaly/complications , Microcephaly/diagnosis , Optic Atrophy/complications , Optic Atrophy/diagnosis , Peripheral Nervous System Diseases/diagnosis , Peripheral Nervous System Diseases/etiology , PhenotypeABSTRACT
OBJECTIVE: Ganglioside-induced differentiation associated-protein 1 (GDAP1) mutations are commonly associated with autosomal recessive Charcot-Marie-Tooth (ARCMT) neuropathy; however, in rare instances, they also lead to autosomal dominant Charcot-Marie-Tooth (ADCMT). We aimed to investigate the frequency of disease-causing heterozygous GDAP1 mutations in ADCMT and their associated phenotype. METHODS: We performed mutation analysis in a large cohort of ADCMT patients by means of bidirectional sequencing of coding regions and exon-intron boundaries of GDAP1. Intragenic GDAP1 deletions were excluded using an allele quantification assay. We confirmed the pathogenic character of one sequence variant by in vitro experiments assaying mitochondrial morphology and function. RESULTS: In 8 Charcot-Marie-Tooth disease (CMT) families we identified 4 pathogenic heterozygous GDAP1 mutations, 3 of which are novel. Three of the mutations displayed reduced disease penetrance. Disease onset in the affected individuals was variable, ranging from early childhood to adulthood. Disease progression was slow in most patients and overall severity milder than typically seen in autosomal recessive GDAP1 mutations. Electrophysiologic changes are heterogeneous but compatible with axonal neuropathy in the majority of patients. CONCLUSIONS: With this study, we broaden the phenotypic and genetic spectrum of autosomal dominant GDAP1-associated neuropathies. We show that patients with dominant GDAP1 mutations may display clear axonal CMT, but may also have only minimal clinical and electrophysiologic abnormalities. We demonstrate that cell-based functional assays can be reliably used to test the pathogenicity of unknown variants. We discuss the implications of phenotypic variability and the reduced penetrance of autosomal dominant GDAP1 mutations for CMT diagnostic testing and counseling.
Subject(s)
Charcot-Marie-Tooth Disease/genetics , Nerve Tissue Proteins/genetics , Animals , Axons/pathology , COS Cells , Chlorocebus aethiops , Cohort Studies , DNA Mutational Analysis , Exons/genetics , Genes, Dominant , Haplotypes , HeLa Cells , Humans , Introns/genetics , Mitochondria/metabolism , Mitochondria/pathology , Mutation , Paternity , Pedigree , Phenotype , Reverse Transcriptase Polymerase Chain ReactionABSTRACT
Among 57 mutations in the peripheral myelin protein 22 gene (PMP22) identified so far in patients affected by Charcot-Marie-Tooth disease (CMT), only 8 have been shown to segregate with a mixed phenotype of CMT and hearing impairment. In this study, we report a new Ser112Arg mutation in the PMP22 gene, identified in a patient with early-onset CMT and slowly progressive hearing impairment beginning in the second decade of life. We suggest that the Ser112Arg mutation in the PMP22 gene might have a causative role in the early-onset CMT with hearing impairment. Thus, our study extends the spectrum of CMT phenotypes putatively associated with PMP22 gene mutations.
Subject(s)
Charcot-Marie-Tooth Disease/genetics , Hearing Disorders/genetics , Myelin Proteins/genetics , Adolescent , Adult , Age of Onset , Aging/genetics , Amino Acid Sequence , Amino Acid Substitution , Arginine/metabolism , Audiometry , Charcot-Marie-Tooth Disease/complications , Child , Child, Preschool , Conserved Sequence , Hearing Disorders/complications , Humans , Male , Molecular Sequence Data , Phenotype , Serine/geneticsABSTRACT
Within the last decade, numerous methods have been applied to detect the most common mutation in patients affected with Charcot-Marie-Tooth (CMT) disease, i.e. submicroscopic duplication in the 17p11.2--p12 region. In 1993, another neuropathy - known as hereditary neuropathy with liability to pressure palsies (HNPP) - has been shown to be caused by a 17p11.2--p12 deletion. Historically, Southern blot analysis was the first approach to identify CMT1A duplication or HNPP deletion. This time- and labor-consuming method requires prior selection of DNA samples. In fact, only CMT patients affected with the demyelinating form of CMT1 have been screened for CMT1A duplication. After the 17p11.2--p12 duplication was identified in the CMT1 families, subsequent studies revealed additional axonal features in the patients harboring the 17p11.2--p12 duplication. Thus it seems reasonable to test all patients affected with CMT for the presence of the 17p11.2--p12 duplication. To evaluate the utility of real-time polymerase chain reaction (Q-PCR) and restriction fragment length polymorphism PCR (RFLP-PCR), we screened a large group of 179 families with the diagnosis of CMT/HNPP for the presence of the 17p11.2--p12 duplication/deletion. Due to a high frequency of CMT1A duplication in familial cases of CMT, we propose (in contrast to the previous studies) to perform Q-PCR analysis in all patients diagnosed with CMT.
Subject(s)
Charcot-Marie-Tooth Disease/genetics , Chromosomes, Human, Pair 17/genetics , Myelin Proteins/genetics , Proteins/genetics , Charcot-Marie-Tooth Disease/diagnosis , Chromosome Deletion , Gene Duplication , Humans , Pedigree , Polymerase Chain Reaction/methodsABSTRACT
Charcot-Marie-Tooth type 1X (CMT1X) disease is inherited as an X-linked dominant trait. Female CMT1X patients are usually mildly affected or even asymptomatic carriers of mutations in the GJB1 gene coding for a gap junction protein called connexin-32 (Cx32). In this report, a five-generation CMT1X family is described from which the new mutation in the GJB1 gene Cys179Gly was identified. The Cys179Gly mutation is located in the highly conservative domain of the Cx32 protein. Previous functional studies performed in the oocyte system have shown that point mutations in the highly conserved Cx32 cysteine residues result in a complete loss of function of the gap junction. However, despite severe biochemical defects, the Cys179Gly mutation segregates with a mild CMT1X phenotype. This study further documents a discrepancy between biochemical effects of GJB1 mutations and the CMT1X phenotype.
Subject(s)
Charcot-Marie-Tooth Disease/genetics , Connexins/genetics , Mutation , Adolescent , Adult , Female , Genetic Diseases, X-Linked , Humans , Male , Middle Aged , Pedigree , Polymorphism, Single-Stranded Conformational , Sequence Analysis , Gap Junction beta-1 ProteinABSTRACT
In recent years, 13 loci and 10 genes have been identified in Charcot-Marie-Tooth disorders with a recessive mode of inheritance (AR-CMT). Accordingly, the entity of AR-CMT has been divided into subgroups on the basis of genetic linkage. Mutations in the MTMR2, MTMR13, GDAP1, PRX, CTDPI, KIAA1985 and NDRG1 genes have been shown to be associated with specific CMT phenotypes. In AR-CMT disorders associated with mutations in the LMNA and MED25 genes the number of patients is still too low to achieve reliable phenotype-genotype correlations. In the present review, we summarize molecular, electrophysiological, neuropathological and clinical aspects of AR-CMT disorders.
Subject(s)
Charcot-Marie-Tooth Disease/genetics , Charcot-Marie-Tooth Disease/physiopathology , Genes, Recessive , Charcot-Marie-Tooth Disease/pathology , HumansABSTRACT
Charcot-Marie-Tooth type 4C4 disease (CMT4C4) is an early onset, autosomal recessive neuropathy with hoarseness caused by mutations in the GDAP1 gene which maps to the 8q13 region. To date, only 24 mutations in the GDAP1 gene have been reported. Neuropathological findings of sural nerve biopsies have been published for a limited number of CMT4C4 patients. Herein, a novel Pro153Leu mutation in the GDAP1 gene identified in a consanguineous Polish family is described and longitudinal clinical and electrophysiological studies as well as morphological findings are presented.
Subject(s)
Charcot-Marie-Tooth Disease/genetics , Mutation , Nerve Tissue Proteins/genetics , Adult , Amino Acid Sequence , Charcot-Marie-Tooth Disease/diagnosis , Charcot-Marie-Tooth Disease/pathology , GTP Phosphohydrolases/genetics , Genotype , Humans , Leucine , Male , Membrane Proteins/genetics , Membrane Transport Proteins/genetics , Mitochondrial Membrane Transport Proteins , Mitochondrial Proteins/genetics , Molecular Sequence Data , Muscular Atrophy , Phenotype , Poland , ProlineABSTRACT
Mutations in the ganglioside -induced differentiation-associated protein 1 (GDAP1) gene are common a cause of the Charcot-Marie-Tooth (CMT4A) disease with autosomal recessive mode of inheritance. To date more than twenty mutations in the GDAP1 gene have been reported in patients suffering from the demyelinating, axonal or mixed form of Charcot-Marie-Tooth disease. Only in a few CMT4A affected patients sural nerve biopsy findings have been provided. We report a homozygous Leu239Phe mutation in the GDAP1 gene in a 39-year-old female with a severe form of mixed axonal and demyelinating Charcot-Marie-Tooth disease.
Subject(s)
Charcot-Marie-Tooth Disease/genetics , Nerve Tissue Proteins/genetics , Adult , Age of Onset , Charcot-Marie-Tooth Disease/pathology , Child, Preschool , Female , HumansABSTRACT
Charcot-Marie-Tooth type 4F disease (CMT4F) is an autosomal recessive neuropathy caused by mutations in the PRX gene. To date, only seven mutations have been identified in the PRX gene. In this study, the authors report a novel S399fsX410 mutation in the PRX gene and its effects at the protein level, which was identified in an 8-year-old patient with early-onset CMT disease.
Subject(s)
Charcot-Marie-Tooth Disease/genetics , Membrane Proteins/genetics , Sequence Deletion , Age of Onset , Charcot-Marie-Tooth Disease/pathology , Child , Exons , Genetic Carrier Screening , Humans , Male , Sural Nerve/pathologyABSTRACT
A recessive demyelinating subtype of Charcot-Marie-Tooth disease called CMT4 is a heterogeneous group of disorders. A relatively frequent form of recessive CMT (CMT4 A) has been mapped to the chromosome 8 q21 and shown to be caused by mutations in the ganglioside-induced differentiation protein 1 (GDAP1) gene. Twenty mutations in the GDAP1 gene have been reported in patients suffering from the axonal and demyelinating forms of CMT disease. In this study we report two novel mutations in the GDAP1 gene in a patient suffering from CMT2 disease and whose parents were asymptomatic carriers of a Ser130Cys and 3'-splice site (311-1G > A) mutation, respectively.
Subject(s)
Charcot-Marie-Tooth Disease/genetics , Mutation/genetics , Nerve Tissue Proteins/genetics , RNA Splice Sites/genetics , Charcot-Marie-Tooth Disease/pathology , Charcot-Marie-Tooth Disease/physiopathology , Child , Humans , Male , Median Nerve/pathology , Median Nerve/physiopathology , Neural Conduction/physiology , Peroneal Nerve/pathology , Peroneal Nerve/physiopathology , Sural Nerve/pathology , Sural Nerve/physiopathologyABSTRACT
Congenital hypomyelinating neuropathy (CHN; MIM# 605253) is a severe neuropathy with early infancy onset inherited as an autosomal dominant or recessive trait. Sural nerve biopsy shows a characteristic picture of nonmyelinated and poorly myelinated axons with basal lamina onion bulbs and lack of myelin breakdown products. Several mutations in the MTMR2, PMP22, EGR2, and MPZ genes have been found in patients with CHN. The authors describe the clinical and morphologic features of a patient with CHN and the identification of a novel Thr124Lys mutation in the MPZ gene.
Subject(s)
Hereditary Central Nervous System Demyelinating Diseases/genetics , Hereditary Sensory and Motor Neuropathy/genetics , Mutation, Missense , Myelin P0 Protein/genetics , Point Mutation , Abnormalities, Multiple/genetics , Amino Acid Substitution , Child , Diseases in Twins , Exons/genetics , Genes, Dominant , Hereditary Central Nervous System Demyelinating Diseases/congenital , Hereditary Central Nervous System Demyelinating Diseases/pathology , Hereditary Sensory and Motor Neuropathy/pathology , Humans , Male , Microscopy, Electron , Muscle Hypotonia/congenital , Muscle Hypotonia/genetics , Myelin P0 Protein/chemistry , Nerve Fibers, Myelinated/pathology , Polymorphism, Single-Stranded Conformational , Reflex, Abnormal , Scoliosis/genetics , Sural Nerve/physiopathology , Sural Nerve/ultrastructureABSTRACT
Charcot-Marie-Tooth type 1B disease is a demyelinating neuropathy caused by mutations in the Myelin Protein Zero gene. It is inherited in an autosomal dominant fashion. So far only a few patients with a focally folded myelin phenotype on nerve biopsy have been shown to have mutations in the Myelin Protein Zero gene. In this report we describe a Polish patient with Charcot-Marie-Tooth type 1B disease. Sural nerve biopsy demonstrated focally folded myelin. Molecular genetic analysis of the coding region of the Myelin Protein Zero gene revealed a novel mutation, Thr65Ala, in exon 2 of the Myelin Protein Zero gene.